Common Stock, Shares, Issued of C4 Therapeutics, Inc. from Q4 2019 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
C4 Therapeutics, Inc. quarterly Common Stock, Shares, Issued history and change rate from Q4 2019 to Q3 2025.
  • C4 Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2025 was 74.2M shares, a 5.12% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)

C4 Therapeutics, Inc. Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 74.2M +3.61M +5.12% Sep 30, 2025 10-Q 2025-11-06
Q2 2025 71M +2.19M +3.19% Jun 30, 2025 10-Q 2025-08-07
Q1 2025 71M +2.21M +3.22% Mar 31, 2025 10-Q 2025-05-07
Q4 2024 70.6M +10.2M +16.8% Dec 31, 2024 10-Q 2025-11-06
Q3 2024 70.6M +21.3M +43.2% Sep 30, 2024 10-Q 2024-10-31
Q2 2024 68.8M +19.8M +40.3% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 68.8M +19.7M +40.2% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 60.5M +11.5M +23.5% Dec 31, 2023 10-K 2025-02-27
Q3 2023 49.3M +309K +0.63% Sep 30, 2023 10-Q 2023-11-01
Q2 2023 49.1M +187K +0.38% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 49.1M +301K +0.62% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 49M +277K +0.57% Dec 31, 2022 10-K 2024-02-22
Q3 2022 49M +358K +0.74% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 48.9M +498K +1.03% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 48.8M +5.64M +13.1% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 48.7M +5.63M +13.1% Dec 31, 2021 10-K 2023-02-23
Q3 2021 48.6M +47M +2874% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 48.4M Jun 30, 2021 10-Q 2021-08-11
Q1 2021 43.1M Mar 31, 2021 10-Q 2021-05-13
Q4 2020 43.1M +41.6M +2918% Dec 31, 2020 10-K 2022-02-24
Q3 2020 1.63M Sep 30, 2020 10-Q 2020-11-12
Q4 2019 1.43M Dec 31, 2019 10-K 2021-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.